Anixa Biosciences is trading 10.06% up at $3.50, but no clear company-specific catalyst has been identified for August 17, 2026.

  • CEO Amit Kumar’s purchase of 5,000 shares was reported August 3.
  • The transaction predates the move and does not clearly explain it.
  • The broader market is slightly lower, providing no clear market-wide explanation.